ACRES Commercial Realty Corp.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Mark S. Fogel
- Full Time Employees
- 4
- Sector
- Finance
- Industry
- Real estate investment trusts
- Address
- 390 RXR Plaza Uniondale NY United States 11556
- IPO Date
- Feb 7, 2006
- CIK
- 0001332551
- Website
- acresreit.com
- Similar Companies
- Business
- ACRES Commercial Realty Corp. (NYSE: ACR), a real estate investment trust founded in 2005 and headquartered at 390 RXR Plaza in Uniondale, New York, originates, holds and manages commercial real estate mortgage loans and related debt investments across the United States; its portfolio encompasses whole loans, mezzanine loans, A-notes, B-notes, preferred equity, commercial mortgage-backed securities and equity stakes through direct ownership or joint ventures, with a focus on middle-market properties in multifamily, student housing, hospitality, office and industrial sectors in top U.S. markets. Externally managed by ACRES Capital, LLC, a subsidiary of ACRES Capital Corp., the company targets transitional floating-rate loans typically ranging from $10 million to $100 million and derives income from interest payments, rental yields and strategic asset sales. Recent developments include refinancing two securitizations into a non-mark-to-market financing facility with JPMorgan post-2024 year-end, enabling a two-year reinvestment period; expansion of the share repurchase program by $10 million in 2025 for common and preferred stock; redemption of CRE securitizations and closing of a $940 million managed facility backed by commercial mortgage loans; and plans to grow the loan portfolio through new originations with experienced sponsors in high-growth markets amid healthy 2024 payoffs and renewed transactional activity.
Company News
ACRES Commercial Realty Corp. (ACR) Q3 2026 Earnings Call Transcript
argenx Presents Phase 3 ALKIVIA Data at ACR Convergence 2026 Showing Rapid and Sustained Improvement with Efgartigimod in Autoimmune Myositis
What ACRES Commercial Realty (ACR) Said on Its Q3 Earnings Call
Acrivon Expands into Immunology and Inflammation with Acquisition of Phase 2-Ready Differentiated, Oral JAK1 Inhibitor ACR-525, and PKCθ Inhibitor Preclinical Program from Aqilion AB
Lilly to showcase new retatrutide, Taltz (ixekizumab) and Zepbound (tirzepatide) data at ACR Convergence 2026, advancing science at the intersection of rheumatologic conditions and obesity
ACRES Commercial (ACR) Reports Q3 Loss, Tops Revenue Estimates
ACRES COMMERCIAL REALTY CORP. REPORTS RESULTS FOR THIRD QUARTER 2026
ACRES Commercial Realty (ACR) Set to Announce Quarterly Earnings on Wednesday
KBRA Publishes Ratings for ACRES Commercial Realty Corp.
Acrivon Announces Late-Breaking Oral Plenary Presentation of Early Phase 1/2 Clinical Results in AP3-Predicted Tumors for its First-in-Class WEE1/PKMYT1 Inhibitor ACR-2316 at the 38th EORTC-NCI-AACR Symposium
ACRES Commercial Realty Corp. to Report Results for Third Quarter 2026
Acrivon Advances ACR-7280, an Optimized, AP3-Enabled, Potential First-in-Class, Oral CDK11 Inhibitor Toward IND Filing in First Half of 2027
CRISPR Therapeutics to Present Clinical Data on Zugocabtagene Geleucel (Zugo-cel) in Autoimmune Disease at the American College of Rheumatology (ACR) Convergence 2026
Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at the American College of Rheumatology (ACR) Convergence 2026
ACRES Commercial (ACR) Moves 9.5% Higher: Will This Strength Last?
ACRES Commercial Realty Corp. Reauthorizes an Additional $5 Million Share Repurchase Program
ACRES Commercial Realty Corp (ACR) Stock Down 4.4% -- Now Undervalued? GF Score: 57/100
TiVo Ads Launches Enhanced U.S. TV Viewership Data Offering, Unifying STB and ACR Data in a Single Feed
Zenas BioPharma Announces Upcoming Presentations of Obexelimab Data in IgG4-Related Disease at the IgG4ward! 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026
ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock